Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer™ as Published in JACC
NASDAQ, TSX: NVCN VANCOUVER, Dec. 11, 2018 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN)(TSX:NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today...
Read More